Hayder Hashim, MD
Cardiovascular Disease · Washington, DCNPI 1104069442
Payments from drug & device makers
Across 1,375 payments — averaging $718.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$336K
- Boston Scientific$251K
- Shockwave Medical, Inc$126K
- Philips North America LLC$47K
- Medtronic$47K
- Chiesi USA, Inc.$46K
- plus $134K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 424 | $335,817 |
| Boston Scientific | 287 | $250,994 |
| Shockwave Medical, Inc | 28 | $126,073 |
| Philips North America LLC | 36 | $47,443 |
| Medtronic | 78 | $47,412 |
| Chiesi USA, Inc. | 46 | $46,389 |
| Cardiovascular Systems Inc. | 156 | $37,232 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 57 | $35,451 |
| Cordis US CORP. | 13 | $25,697 |
| Penumbra, Inc. | 23 | $18,410 |
| Terumo Medical Corporation | 17 | $9,630 |
| Abiomed | 29 | $1,738 |
| Amgen | 35 | $1,106 |
| AstraZeneca | 43 | $902 |
| Teleflex LLC | 13 | $771 |
| Asahi Intecc USA, Inc. | 5 | $433 |
| Acist Medical Systems, Inc. | 1 | $346 |
| Novo Nordisk | 15 | $323 |
| E.r. Squibb & Sons, L.L.C. | 11 | $300 |
| Pfizer | 17 | $297 |
| Cook Medical LLC | 6 | $278 |
| Biotronik Inc. | 3 | $240 |
| Johnson & Johnson | 11 | $207 |
| ZOLL Circulation Inc | 2 | $198 |
| Opsens Inc. | 1 | $157 |
| Novartis | 6 | $145 |
| W. L. Gore & Associates, Inc. | 1 | $117 |
| Inari Medical, Inc. | 1 | $115 |
| Siemens Medical Solutions USA, Inc. | 2 | $111 |
| Celonova Biosciences, Inc. | 1 | $49 |
| Atricure, Inc. | 2 | $42 |
| Recor Medical Inc | 2 | $37 |
| Cardiva Medical, Inc. | 1 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
How this compares
$988,540 in reported general payments places this provider in the 95th percentile of 105 cardiovascular disease providers in District of Columbia.
See all cardiovascular disease providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Washington
- Felton AndersonWashington$2.3M
- Neil WeissmanWashington$1.9M
- Mardi Gomberg-MaitlandWashington$1.1M
- Joshua YamamotoWashington$376K
- Jaffar KhanWashington$330K
- Susan O'DonoghueWashington$207K
- Richard KatzWashington$207K
- Isaac Opoku-AsareWashington$146K
- Zuyue WangWashington$143K
- Andrew ChoiWashington$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.